Diaphorina citri psyllid: psy6599

Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90---
MNVGTDNSLGDRLLDIPCKVCGDRSSGKHYGIYSCDGCSGFFKRSIHRNRVYTCKAQGDLKGHCPIDKTHRNQCRACRLNKCFMSAMNKDDFK
ccccccccccccccccccCECccccccEECcCEccccccccccccEEcccCEECcccccccccccccccccccccHHHHHHHHHHcccccccc
*************LDIPCKVCGDRSSGKHYGIYSCDGCSGFFKRSIHRNRVYTCKAQGDLKGHCPIDKTHRNQCRACRLNKCFMSAMNK****
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MNVGTDNSLGDRLLDIPCKVCGDRSSGKHYGIYSCDGCSGFFKRSIHRNRVYTCKAQGDLKGHCPIDKTHRNQCRACRLNKCFMSAMNKDDFK

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Nuclear receptor subfamily 2 group E member 1 Orphan receptor that binds DNA as a monomer to hormone response elements (HRE) containing an extended core motif half-site sequence 5'-AAGGTCA-3' in which the 5' flanking nucleotides participate in determining receptor specificity. May be required to pattern anterior brain differentiation (By similarity). Involved in the regulation of retinal development.confidentQ91379
Nuclear receptor subfamily 2 group E member 1 Orphan receptor that binds DNA as a monomer to hormone response elements (HRE) containing an extended core motif half-site sequence 5'-AAGGTCA-3' in which the 5' flanking nucleotides participate in determining receptor specificity (By similarity). Regulates cell cycle progression in neural stem cells of rhe developing brain. Involved in the regulation of retinal development and essential for vision. During retinogenesis, regulates PTEN-Cyclin D expression via binding to the promoter region of PTEN and suppressing its activity. May be involved in retinoic acid receptor (RAR) regulation in retinal cells.confidentQ64104
Nuclear receptor subfamily 2 group E member 1 Orphan receptor that binds DNA as a monomer to hormone response elements (HRE) containing an extended core motif half-site sequence 5'-AAGGTCA-3' in which the 5' flanking nucleotides participate in determining receptor specificity (By similarity). May be required to pattern anterior brain differentiation. Involved in the regulation of retinal development and essential for vision. During retinogenesis, regulates PTEN-Cyclin D expression via binding to the promoter region of PTEN and suppressing its activity (By similarity). May be involved in retinoic acic receptor (RAR) regulation in retinal cells.confidentQ9Y466

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0001078 [MF]RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcriptionconfidentGO:0001227, GO:0003700, GO:0003674, GO:0001071, GO:0000982, GO:0000981
GO:0048384 [BP]retinoic acid receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0030522, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0050789, GO:0044699
GO:0000122 [BP]negative regulation of transcription from RNA polymerase II promoterprobableGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0006357, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0045892, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0008150, GO:0010558, GO:0048523
GO:0046982 [MF]protein heterodimerization activityprobableGO:0046983, GO:0003674, GO:0005488, GO:0005515
GO:0048047 [BP]mating behavior, sex discriminationprobableGO:0044703, GO:0000003, GO:0007618, GO:0019098, GO:0007617, GO:0050896, GO:0007610, GO:0022414, GO:0008150, GO:0051705, GO:0051704
GO:0008049 [BP]male courtship behaviorprobableGO:0060179, GO:0044703, GO:0032501, GO:0032504, GO:0048609, GO:0007618, GO:0019098, GO:0007617, GO:0050896, GO:0007619, GO:0007610, GO:0022414, GO:0008150, GO:0044706, GO:0033057, GO:0000003, GO:0051705, GO:0051704
GO:0003705 [MF]RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activityprobableGO:0003700, GO:0003674, GO:0001071, GO:0000981
GO:0001077 [MF]RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcriptionprobableGO:0003700, GO:0001228, GO:0003674, GO:0001071, GO:0000982, GO:0000981
GO:0035206 [BP]regulation of hemocyte proliferationprobableGO:0042127, GO:0050793, GO:0050794, GO:0008150, GO:0002682, GO:0051239, GO:0065007, GO:0050789
GO:0004886 [MF]9-cis retinoic acid receptor activityprobableGO:0003708, GO:0038023, GO:0003700, GO:0001071, GO:0060089, GO:0003674, GO:0004879, GO:0004871, GO:0000981, GO:0004872
GO:0005667 [CC]transcription factor complexprobableGO:0043234, GO:0044446, GO:0032991, GO:0005575, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0005654, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0044424, GO:0044451, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0031641 [BP]regulation of myelinationprobableGO:0051239, GO:0044057, GO:0031644, GO:0032844, GO:0008150, GO:0050793, GO:2000021, GO:2000026, GO:0051960, GO:0023051, GO:0065007, GO:0051969, GO:0010646, GO:0050789, GO:0050794
GO:0045944 [BP]positive regulation of transcription from RNA polymerase II promoterprobableGO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0007596 [BP]blood coagulationprobableGO:0032501, GO:0007599, GO:0044707, GO:0050878, GO:0050896, GO:0009611, GO:0042060, GO:0006950, GO:0050817, GO:0008150, GO:0065007, GO:0065008, GO:0044699
GO:0033159 [BP]negative regulation of protein import into nucleus, translocationprobableGO:0033157, GO:0070201, GO:0032879, GO:0060341, GO:0051051, GO:1900180, GO:0051049, GO:0032386, GO:0032387, GO:0090317, GO:0033158, GO:0050794, GO:0008150, GO:0065007, GO:0046822, GO:0048519, GO:0042306, GO:0051223, GO:0051224, GO:0050789, GO:0032880
GO:0044323 [MF]retinoic acid-responsive element bindingprobableGO:0044212, GO:0097159, GO:0000975, GO:0001067, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0030853 [BP]negative regulation of granulocyte differentiationprobableGO:0002761, GO:0051093, GO:0002762, GO:0045596, GO:0050793, GO:0050789, GO:1902105, GO:0050794, GO:0030852, GO:1902106, GO:0045638, GO:0065007, GO:0002682, GO:0008150, GO:0051239, GO:0048519, GO:2000026, GO:0045595, GO:0045637, GO:0048523
GO:0030850 [BP]prostate gland developmentprobableGO:0032502, GO:0032501, GO:0048608, GO:0000003, GO:0044707, GO:0022414, GO:0061458, GO:0048856, GO:0044767, GO:0003006, GO:0048513, GO:0008150, GO:0001655, GO:0048731, GO:0048732, GO:0007275, GO:0044699
GO:0035176 [BP]social behaviorprobableGO:0050896, GO:0007610, GO:0008150, GO:0051703, GO:0051705, GO:0051704
GO:0035271 [BP]ring gland developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0035270, GO:0048513, GO:0008150, GO:0048731, GO:0048732, GO:0007275, GO:0044699
GO:0001754 [BP]eye photoreceptor cell differentiationprobableGO:0044707, GO:0030154, GO:0009653, GO:0007275, GO:0044699, GO:0048869, GO:0008150, GO:0048513, GO:0032502, GO:0009887, GO:0032501, GO:0030182, GO:0048592, GO:0009987, GO:0044767, GO:0044763, GO:0048731, GO:0022008, GO:0048699, GO:0007399, GO:0007423, GO:0048856, GO:0046530, GO:0001654
GO:0009605 [BP]response to external stimulusprobableGO:0050896, GO:0008150
GO:0006591 [BP]ornithine metabolic processprobableGO:0044238, GO:0044710, GO:0009987, GO:1901564, GO:0006082, GO:0044237, GO:0006520, GO:0019752, GO:0071704, GO:0006807, GO:0008150, GO:0044281, GO:0008152, GO:0043436, GO:1901605
GO:0000900 [MF]translation repressor activity, nucleic acid bindingprobableGO:0090079, GO:0003676, GO:0097159, GO:0030371, GO:0003674, GO:0005488, GO:0045182, GO:1901363
GO:0009948 [BP]anterior/posterior axis specificationprobableGO:0032502, GO:0007389, GO:0032501, GO:0009952, GO:0044707, GO:0008150, GO:0003002, GO:0009798, GO:0007275, GO:0044699
GO:0005652 [CC]nuclear laminaprobableGO:0034399, GO:0005575, GO:0043231, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0044424, GO:0043227, GO:0043226, GO:0044422
GO:0042826 [MF]histone deacetylase bindingprobableGO:0003674, GO:0005515, GO:0019899, GO:0005488
GO:0007620 [BP]copulationprobableGO:0044703, GO:0000003, GO:0007618, GO:0022414, GO:0008150, GO:0051704
GO:0060164 [BP]regulation of timing of neuron differentiationprobableGO:0030154, GO:0050789, GO:0044699, GO:0050767, GO:0048869, GO:0060284, GO:0007275, GO:0045664, GO:0065007, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0045595, GO:0044763, GO:0051239, GO:0048731, GO:0022008, GO:0040034, GO:0048699, GO:0044707, GO:0007399, GO:0048856, GO:0048505, GO:0051960, GO:2000026, GO:0008150
GO:0021895 [BP]cerebral cortex neuron differentiationprobableGO:0030154, GO:0007275, GO:0044699, GO:0007417, GO:0048869, GO:0048513, GO:0021953, GO:0032502, GO:0032501, GO:0030182, GO:0009987, GO:0044767, GO:0008150, GO:0048731, GO:0022008, GO:0048699, GO:0007420, GO:0044707, GO:0048856, GO:0007399, GO:0030900, GO:0044763
GO:0048814 [BP]regulation of dendrite morphogenesisprobableGO:0022604, GO:0044707, GO:0010975, GO:0022603, GO:0030154, GO:0051128, GO:0050789, GO:0044699, GO:0050767, GO:0048869, GO:0060284, GO:0031344, GO:0045664, GO:0010769, GO:0065007, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0045595, GO:0008150, GO:0051239, GO:0022008, GO:0048699, GO:0007399, GO:0050773, GO:0048856, GO:0044763, GO:0051960, GO:2000026, GO:0007275, GO:0048731
GO:0001972 [MF]retinoic acid bindingprobableGO:0043168, GO:0031406, GO:0019840, GO:0008289, GO:0043167, GO:0003674, GO:0005488, GO:0033293, GO:0005501
GO:0031490 [MF]chromatin DNA bindingprobableGO:0043566, GO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:0003682, GO:1901363
GO:0021764 [BP]amygdala developmentprobableGO:0032502, GO:0032501, GO:0007420, GO:0044707, GO:0048856, GO:0007399, GO:0044767, GO:0048513, GO:0030900, GO:0008150, GO:0021761, GO:0048731, GO:0007275, GO:0044699, GO:0007417
GO:0009416 [BP]response to light stimulusprobableGO:0009314, GO:0050896, GO:0008150, GO:0009628
GO:0090049 [BP]regulation of cell migration involved in sprouting angiogenesisprobableGO:1901342, GO:0030334, GO:0010594, GO:0010632, GO:0022603, GO:0050793, GO:0045765, GO:0051270, GO:0008150, GO:0040012, GO:0043535, GO:0065007, GO:2000026, GO:0051239, GO:2000145, GO:0032879, GO:0050794, GO:0050789
GO:0048514 [BP]blood vessel morphogenesisprobableGO:0032502, GO:0032501, GO:0044707, GO:0001568, GO:0048856, GO:0001944, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0051018 [MF]protein kinase A bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0019048 [BP]virus-host interactionprobableGO:0044419, GO:0044703, GO:0000003, GO:0009987, GO:0022415, GO:0022414, GO:0044764, GO:0008150, GO:0016032, GO:0044403, GO:0051701, GO:0051704
GO:0045924 [BP]regulation of female receptivityprobableGO:0060180, GO:0044703, GO:0032501, GO:0032504, GO:0048609, GO:0007618, GO:0019098, GO:0007617, GO:0050896, GO:0044706, GO:0007610, GO:0022414, GO:0065007, GO:0008150, GO:0065008, GO:0033057, GO:0000003, GO:0051705, GO:0051704
GO:0032355 [BP]response to estradiol stimulusprobableGO:1901700, GO:0009719, GO:0033993, GO:0050896, GO:0008150, GO:0014070, GO:0009725, GO:0043627, GO:0042221, GO:0097305, GO:0010033, GO:0048545
GO:0043065 [BP]positive regulation of apoptotic processprobableGO:0050794, GO:0050789, GO:0048518, GO:0043067, GO:0065007, GO:0010942, GO:0008150, GO:0010941, GO:0042981, GO:0043068, GO:0048522
GO:0043066 [BP]negative regulation of apoptotic processprobableGO:0043069, GO:0050794, GO:0008150, GO:0043067, GO:0065007, GO:0060548, GO:0048519, GO:0010941, GO:0042981, GO:0050789, GO:0048523
GO:0048598 [BP]embryonic morphogenesisprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0008150, GO:0009653, GO:0007275, GO:0044699
GO:0019216 [BP]regulation of lipid metabolic processprobableGO:0008150, GO:0065007, GO:0080090, GO:0019222, GO:0050789
GO:0034440 [BP]lipid oxidationprobableGO:0044238, GO:0044710, GO:0006629, GO:0009987, GO:0044237, GO:0071704, GO:0008150, GO:0008152, GO:0044255, GO:0030258, GO:0055114
GO:2000648 [BP]positive regulation of stem cell proliferationprobableGO:0008284, GO:0042127, GO:0050794, GO:0050789, GO:0065007, GO:0048518, GO:0008150, GO:0072091, GO:0048522
GO:0007164 [BP]establishment of tissue polarityprobableGO:0032502, GO:0048856, GO:0044767, GO:0008150, GO:0009653, GO:0044699
GO:0021872 [BP]forebrain generation of neuronsprobableGO:0032502, GO:0032501, GO:0048699, GO:0030154, GO:0007420, GO:0007399, GO:0044707, GO:0048869, GO:0009987, GO:0048856, GO:0044763, GO:0044767, GO:0048513, GO:0030900, GO:0008150, GO:0048731, GO:0022008, GO:0007275, GO:0044699, GO:0007417
GO:0045787 [BP]positive regulation of cell cycleprobableGO:0051726, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0071729 [BP]beak morphogenesisprobableGO:0032502, GO:0071728, GO:0048856, GO:0044767, GO:0008150, GO:0009653, GO:0044699
GO:0045665 [BP]negative regulation of neuron differentiationprobableGO:0030154, GO:0050789, GO:0044699, GO:0050767, GO:0048869, GO:0060284, GO:0007275, GO:0045664, GO:0065007, GO:0048519, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0045596, GO:0045595, GO:0008150, GO:0051239, GO:0022008, GO:0051093, GO:0048699, GO:0044707, GO:0007399, GO:0048856, GO:0044763, GO:0051960, GO:2000026, GO:0048731, GO:0048523
GO:0046966 [MF]thyroid hormone receptor bindingprobableGO:0008134, GO:0035257, GO:0003674, GO:0005488, GO:0005515, GO:0051427, GO:0005102
GO:0000790 [CC]nuclear chromatinprobableGO:0031974, GO:0043229, GO:0043228, GO:0000785, GO:0000228, GO:0043227, GO:0043226, GO:0044446, GO:0031981, GO:0005634, GO:0044454, GO:0005694, GO:0043231, GO:0043232, GO:0043233, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0070013, GO:0044428, GO:0044424, GO:0044427, GO:0044422
GO:0048027 [MF]mRNA 5'-UTR bindingprobableGO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:0003729, GO:1901363, GO:0003723
GO:0016290 [MF]palmitoyl-CoA hydrolase activityprobableGO:0016787, GO:0016289, GO:0016790, GO:0016788, GO:0003824, GO:0003674, GO:0047617
GO:0060395 [BP]SMAD protein signal transductionprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007167, GO:0007154, GO:0050789, GO:0044699, GO:0007178
GO:0055057 [BP]neuroblast divisionprobableGO:0030154, GO:0048103, GO:0007405, GO:0007275, GO:0044699, GO:0048869, GO:0051301, GO:0061351, GO:0032502, GO:0032501, GO:0008283, GO:0009987, GO:0008150, GO:0048731, GO:0022008, GO:0017145, GO:0048699, GO:0007399, GO:0044707, GO:0048856, GO:0044763, GO:0072089
GO:0006468 [BP]protein phosphorylationprobableGO:0044267, GO:0044260, GO:0044238, GO:0019538, GO:0016310, GO:0009987, GO:0043412, GO:0006464, GO:0043170, GO:0071704, GO:0006796, GO:0036211, GO:0008150, GO:0044237, GO:0008152, GO:0006793
GO:0006805 [BP]xenobiotic metabolic processprobableGO:0051716, GO:0008152, GO:0050896, GO:0009987, GO:0044763, GO:0009410, GO:0044237, GO:0071466, GO:0008150, GO:0070887, GO:0042221, GO:0044699
GO:0001764 [BP]neuron migrationprobableGO:0040011, GO:0032502, GO:0048699, GO:0048856, GO:0044707, GO:0007399, GO:0048870, GO:0009987, GO:0048869, GO:0032501, GO:0030154, GO:0006928, GO:0008150, GO:0051674, GO:0044763, GO:0007275, GO:0048731, GO:0022008, GO:0016477, GO:0051179, GO:0044699
GO:0001708 [BP]cell fate specificationprobableGO:0032502, GO:0045165, GO:0048869, GO:0030154, GO:0044763, GO:0008150, GO:0009987, GO:0044699
GO:0006367 [BP]transcription initiation from RNA polymerase II promoterprobableGO:0032774, GO:0090304, GO:0044249, GO:0034641, GO:0006807, GO:0034645, GO:1901362, GO:1901360, GO:1901576, GO:0044260, GO:0071704, GO:0010467, GO:0006366, GO:0018130, GO:0006139, GO:0009987, GO:0006725, GO:0009058, GO:0009059, GO:0008150, GO:0008152, GO:0034654, GO:0046483, GO:0016070, GO:0044238, GO:0044271, GO:0044237, GO:0043170, GO:0006351, GO:0006352, GO:0019438
GO:0020037 [MF]heme bindingprobableGO:0005488, GO:0097159, GO:0003674, GO:1901363, GO:0046906
GO:0035019 [BP]somatic stem cell maintenanceprobableGO:0030154, GO:0048468, GO:0050789, GO:0044699, GO:0048863, GO:0048864, GO:0048869, GO:0065007, GO:0048519, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0044767, GO:0045596, GO:0045595, GO:0008150, GO:0051093, GO:0019827, GO:0044707, GO:0048856, GO:0044763, GO:0048523
GO:0002118 [BP]aggressive behaviorprobableGO:0050896, GO:0008150, GO:0007610, GO:0051705, GO:0051704
GO:0006637 [BP]acyl-CoA metabolic processprobableGO:0035383, GO:0051186, GO:0006732, GO:0009987, GO:0044237, GO:0071704, GO:0008150, GO:0008152, GO:0006793
GO:0019953 [BP]sexual reproductionprobableGO:0008150, GO:0000003
GO:0071391 [BP]cellular response to estrogen stimulusprobableGO:0071495, GO:0009719, GO:0051716, GO:0008150, GO:0071407, GO:0071383, GO:0009987, GO:0071396, GO:0071310, GO:0044699, GO:0009725, GO:0050896, GO:0032870, GO:0044763, GO:0014070, GO:0070887, GO:0033993, GO:0043627, GO:0042221, GO:0010033, GO:0048545
GO:0021772 [BP]olfactory bulb developmentprobableGO:0032502, GO:0021537, GO:0044707, GO:0007420, GO:0007399, GO:0032501, GO:0048856, GO:0044767, GO:0021988, GO:0048513, GO:0030900, GO:0048731, GO:0008150, GO:0007275, GO:0044699, GO:0007417
GO:0060291 [BP]long-term synaptic potentiationprobableGO:0010646, GO:0044057, GO:0031644, GO:0031646, GO:0051240, GO:0050806, GO:0010647, GO:0050804, GO:0023056, GO:0050789, GO:0048167, GO:0065007, GO:0051239, GO:0023051, GO:0048518, GO:0008150, GO:0051969, GO:0065008, GO:0051971, GO:0050794, GO:0048522
GO:0055012 [BP]ventricular cardiac muscle cell differentiationprobableGO:0030154, GO:0072359, GO:0072358, GO:0051146, GO:0061061, GO:0007275, GO:0044699, GO:0048869, GO:0008150, GO:0048513, GO:0032502, GO:0032501, GO:0055007, GO:0009987, GO:0035051, GO:0009888, GO:0044767, GO:0044763, GO:0007507, GO:0044707, GO:0048856, GO:0014706, GO:0048738, GO:0060537, GO:0048731, GO:0042692
GO:0045216 [BP]cell-cell junction organizationprobableGO:0034330, GO:0009987, GO:0016043, GO:0044763, GO:0044699, GO:0008150, GO:0071840
GO:0045930 [BP]negative regulation of mitotic cell cycleprobableGO:0007346, GO:0045786, GO:0051726, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0060037 [BP]pharyngeal system developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0048731, GO:0043009, GO:0007275, GO:0044699
GO:0045471 [BP]response to ethanolprobableGO:1901700, GO:0050896, GO:0008150, GO:0042221, GO:0097305, GO:0010033
GO:0035295 [BP]tube developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0008150, GO:0007275, GO:0044699
GO:0008347 [BP]glial cell migrationprobableGO:0040011, GO:0032502, GO:0048856, GO:0044707, GO:0007399, GO:0048870, GO:0009987, GO:0048869, GO:0032501, GO:0030154, GO:0042063, GO:0006928, GO:0008150, GO:0051674, GO:0044763, GO:0007275, GO:0048731, GO:0022008, GO:0016477, GO:0051179, GO:0044699
GO:0061037 [BP]negative regulation of cartilage developmentprobableGO:0051093, GO:0050793, GO:0065007, GO:0008150, GO:0061035, GO:2000026, GO:0051239, GO:0048519, GO:0050789
GO:0003707 [MF]steroid hormone receptor activityprobableGO:0003674, GO:0038023, GO:0004872, GO:0004871, GO:0060089
GO:0032754 [BP]positive regulation of interleukin-5 productionprobableGO:0051240, GO:0001817, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0032674, GO:0050789, GO:0001819
GO:0003714 [MF]transcription corepressor activityprobableGO:0003674, GO:0003712, GO:0000989, GO:0000988
GO:0048584 [BP]positive regulation of response to stimulusprobableGO:0048518, GO:0065007, GO:0048583, GO:0050789, GO:0008150
GO:0008502 [MF]melatonin receptor activityprobableGO:0004930, GO:0038023, GO:0060089, GO:0004888, GO:0003674, GO:0004872, GO:0004871
GO:0032736 [BP]positive regulation of interleukin-13 productionprobableGO:0032656, GO:0051240, GO:0001817, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0050789, GO:0001819
GO:0001893 [BP]maternal placenta developmentprobableGO:0060135, GO:0007275, GO:0044699, GO:0000003, GO:0048513, GO:0044706, GO:0032502, GO:0032501, GO:0048609, GO:0032504, GO:0044767, GO:0022414, GO:0008150, GO:0001890, GO:0051704, GO:0044703, GO:0044702, GO:0044707, GO:0003006, GO:0007565, GO:0048856, GO:0048731
GO:0003417 [BP]growth plate cartilage developmentprobableGO:0048705, GO:0048589, GO:0060349, GO:0060348, GO:0001501, GO:0009653, GO:0007275, GO:0044699, GO:0040007, GO:0048513, GO:0003416, GO:0060560, GO:0060350, GO:0060351, GO:0009887, GO:0032501, GO:0009888, GO:0061448, GO:0044767, GO:0008150, GO:0051216, GO:0044707, GO:0048856, GO:0032502, GO:0048731
GO:0032720 [BP]negative regulation of tumor necrosis factor productionprobableGO:0001817, GO:0051241, GO:0008150, GO:0032680, GO:0065007, GO:0051239, GO:0048519, GO:0050789, GO:0001818
GO:0007601 [BP]visual perceptionprobableGO:0032501, GO:0044707, GO:0050877, GO:0007600, GO:0050953, GO:0008150, GO:0044699, GO:0003008
GO:0043433 [BP]negative regulation of sequence-specific DNA binding transcription factor activityprobableGO:0009889, GO:0051090, GO:0019219, GO:0080090, GO:0019222, GO:0060255, GO:0031326, GO:0031323, GO:0044092, GO:2000112, GO:0050794, GO:0050789, GO:0006355, GO:0010556, GO:0065007, GO:0051171, GO:2001141, GO:0008150, GO:0065009, GO:0051252, GO:0010468
GO:0021819 [BP]layer formation in cerebral cortexprobableGO:0021537, GO:0044707, GO:0006928, GO:0051674, GO:0021885, GO:0009653, GO:0021987, GO:0044699, GO:0007417, GO:0051179, GO:0021799, GO:0048513, GO:0016477, GO:0021795, GO:0032502, GO:0032501, GO:0009987, GO:0044767, GO:0021543, GO:0008150, GO:0022029, GO:0040011, GO:0007420, GO:0007399, GO:0048870, GO:0048856, GO:0044763, GO:0030900, GO:0048646, GO:0007275, GO:0048731, GO:0021801
GO:0043025 [CC]neuronal cell bodyprobableGO:0005575, GO:0097458, GO:0044297, GO:0005623, GO:0044464
GO:0001748 [BP]optic lobe placode developmentprobableGO:0044767, GO:0032502, GO:0048856, GO:0008150, GO:0044699
GO:0030375 [MF]thyroid hormone receptor coactivator activityprobableGO:0030545, GO:0030546, GO:0003713, GO:0003712, GO:0030374, GO:0003674, GO:0000989, GO:0000988, GO:0010861
GO:0021542 [BP]dentate gyrus developmentprobableGO:0032502, GO:0044767, GO:0032501, GO:0007420, GO:0044707, GO:0021537, GO:0048856, GO:0007399, GO:0021766, GO:0021543, GO:0048513, GO:0030900, GO:0008150, GO:0021761, GO:0048731, GO:0007275, GO:0044699, GO:0007417
GO:0060041 [BP]retina development in camera-type eyeprobableGO:0032502, GO:0032501, GO:0044707, GO:0007423, GO:0048856, GO:0044767, GO:0048513, GO:0001654, GO:0048731, GO:0008150, GO:0043010, GO:0007275, GO:0044699
GO:0021549 [BP]cerebellum developmentprobableGO:0032502, GO:0044707, GO:0007420, GO:0007399, GO:0032501, GO:0048856, GO:0022037, GO:0044767, GO:0048513, GO:0008150, GO:0030902, GO:0048731, GO:0007275, GO:0044699, GO:0007417
GO:0005730 [CC]nucleolusprobableGO:0005575, GO:0043232, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0031974, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0043228, GO:0044428, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0071300 [BP]cellular response to retinoic acidprobableGO:1901700, GO:1901701, GO:0032526, GO:0033993, GO:0050896, GO:0009987, GO:0071396, GO:0051716, GO:0008150, GO:0071310, GO:0044763, GO:0070887, GO:0042221, GO:0010033, GO:0044699
GO:0045666 [BP]positive regulation of neuron differentiationprobableGO:0030154, GO:0050789, GO:0044699, GO:0050767, GO:0048869, GO:0060284, GO:0007275, GO:0045664, GO:0065007, GO:0048518, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0045597, GO:0045595, GO:0008150, GO:0051239, GO:0022008, GO:0048699, GO:0044707, GO:0007399, GO:0051094, GO:0048856, GO:0044763, GO:0051960, GO:2000026, GO:0048731, GO:0048522
GO:0042809 [MF]vitamin D receptor bindingprobableGO:0008134, GO:0035257, GO:0003674, GO:0005488, GO:0005515, GO:0051427, GO:0005102
GO:0003690 [MF]double-stranded DNA bindingprobableGO:0043566, GO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:2000178 [BP]negative regulation of neural precursor cell proliferationprobableGO:0042127, GO:0008285, GO:0050794, GO:0008150, GO:2000177, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:2000179 [BP]positive regulation of neural precursor cell proliferationprobableGO:0008284, GO:0042127, GO:0050794, GO:2000177, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0042803 [MF]protein homodimerization activityprobableGO:0046983, GO:0003674, GO:0005515, GO:0042802, GO:0005488
GO:0072001 [BP]renal system developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0008150, GO:0001655, GO:0048731, GO:0007275, GO:0044699
GO:0035357 [BP]peroxisome proliferator activated receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0030522, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0050789, GO:0044699
GO:0021960 [BP]anterior commissure morphogenesisprobableGO:0021537, GO:0048666, GO:0044707, GO:0030030, GO:0030154, GO:0048468, GO:0031175, GO:0009653, GO:0007275, GO:0044699, GO:0007417, GO:0000904, GO:0000902, GO:0048869, GO:0016043, GO:0032989, GO:0048513, GO:0071840, GO:0021955, GO:0021954, GO:0021953, GO:0021952, GO:0032502, GO:0048667, GO:0032501, GO:0030182, GO:0009987, GO:0044767, GO:0008150, GO:0007409, GO:0022008, GO:0032990, GO:0007420, GO:0048699, GO:0048858, GO:0007399, GO:0048856, GO:0044763, GO:0048812, GO:0030900, GO:0048731
GO:0048610 [BP]cellular process involved in reproductionprobableGO:0009987, GO:0008150, GO:0000003
GO:0071222 [BP]cellular response to lipopolysaccharideprobableGO:0070887, GO:0032496, GO:0044699, GO:0051716, GO:0033993, GO:0009617, GO:0071310, GO:0071219, GO:0071216, GO:0009987, GO:0071396, GO:0008150, GO:0042221, GO:0051707, GO:0010033, GO:0051704, GO:1901700, GO:1901701, GO:0009607, GO:0050896, GO:0002237, GO:0044763
GO:0048729 [BP]tissue morphogenesisprobableGO:0032502, GO:0048856, GO:0009888, GO:0044767, GO:0008150, GO:0009653, GO:0044699
GO:0009791 [BP]post-embryonic developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0008150, GO:0007275, GO:0044699
GO:0045766 [BP]positive regulation of angiogenesisprobableGO:0022603, GO:0050793, GO:0051094, GO:0045765, GO:0008150, GO:1901342, GO:2000026, GO:0051239, GO:0048518, GO:0065007, GO:0050789
GO:0000977 [MF]RNA polymerase II regulatory region sequence-specific DNA bindingprobableGO:0043565, GO:0044212, GO:0001067, GO:0003677, GO:0001012, GO:0000976, GO:0005488, GO:0003676, GO:0000975, GO:0003674, GO:0097159, GO:1901363
GO:0072539 [BP]T-helper 17 cell differentiationprobableGO:0044707, GO:0072538, GO:0046632, GO:0046631, GO:0045321, GO:0032501, GO:0007275, GO:0044699, GO:0042093, GO:0002286, GO:0002287, GO:0002285, GO:0048869, GO:0002263, GO:0002366, GO:0048534, GO:0043367, GO:0032502, GO:0030154, GO:0030217, GO:0009987, GO:0048731, GO:0044767, GO:0001775, GO:0046649, GO:0008150, GO:0042110, GO:0006955, GO:0002521, GO:0002520, GO:0048513, GO:0002293, GO:0002292, GO:0002294, GO:0002460, GO:0050896, GO:0048856, GO:0044763, GO:0002376, GO:0002250, GO:0030098, GO:0002252, GO:0030097, GO:0035710
GO:0035108 [BP]limb morphogenesisprobableGO:0032502, GO:0048856, GO:0044707, GO:0060173, GO:0035107, GO:0044767, GO:0032501, GO:0008150, GO:0044699, GO:0009653, GO:0007275, GO:0048736
GO:0030424 [CC]axonprobableGO:0044464, GO:0005623, GO:0005575, GO:0097458, GO:0043005, GO:0042995
GO:0023019 [BP]signal transduction involved in regulation of gene expressionprobableGO:0044700, GO:0051716, GO:0019222, GO:0008150, GO:0060255, GO:0050896, GO:0009987, GO:0050794, GO:0050789, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0010468, GO:0044699
GO:0035264 [BP]multicellular organism growthprobableGO:0044699, GO:0032501, GO:0008150, GO:0040007, GO:0044707
GO:0001746 [BP]Bolwig's organ morphogenesisprobableGO:0032502, GO:0009887, GO:0032501, GO:0044707, GO:0007423, GO:0055034, GO:0048592, GO:0048856, GO:0044767, GO:0048513, GO:0001654, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0007517 [BP]muscle organ developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0061061, GO:0048731, GO:0007275, GO:0044699
GO:0070644 [MF]vitamin D response element bindingprobableGO:0044212, GO:0097159, GO:0000975, GO:0001067, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0045995 [BP]regulation of embryonic developmentprobableGO:0050793, GO:0008150, GO:0065007, GO:0051239, GO:2000026, GO:0050789
GO:0008144 [MF]drug bindingprobableGO:0003674, GO:0005488
GO:0018993 [BP]somatic sex determinationprobableGO:0032502, GO:0032501, GO:0000003, GO:0044707, GO:0022414, GO:0003006, GO:0008150, GO:0007275, GO:0044699, GO:0007530
GO:0042524 [BP]negative regulation of tyrosine phosphorylation of Stat5 proteinprobableGO:0010563, GO:0019220, GO:0080090, GO:0019222, GO:0048585, GO:0031324, GO:0048583, GO:0023057, GO:0010648, GO:0023051, GO:0009892, GO:0010646, GO:0010627, GO:0050789, GO:0051248, GO:0010605, GO:0009968, GO:0009966, GO:0045936, GO:0051246, GO:0042532, GO:0065007, GO:0031399, GO:0048519, GO:0010741, GO:0042325, GO:0046426, GO:0046425, GO:0060255, GO:0031323, GO:0050794, GO:0051174, GO:0032268, GO:0008150, GO:0042509, GO:0042522, GO:0032269, GO:0042326, GO:0050730, GO:0031400, GO:0050732, GO:0001933, GO:0001932, GO:0048523
GO:0019904 [MF]protein domain specific bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0030198 [BP]extracellular matrix organizationprobableGO:0009987, GO:0016043, GO:0044763, GO:0044699, GO:0043062, GO:0008150, GO:0071840
GO:0008584 [BP]male gonad developmentprobableGO:0032502, GO:0022414, GO:0007548, GO:0032501, GO:0048608, GO:0000003, GO:0044707, GO:0046546, GO:0061458, GO:0048856, GO:0008406, GO:0045137, GO:0007275, GO:0044767, GO:0003006, GO:0048513, GO:0008150, GO:0048731, GO:0046661, GO:0044699
GO:0048712 [BP]negative regulation of astrocyte differentiationprobableGO:0048710, GO:0030154, GO:0060284, GO:0045686, GO:0045685, GO:0014014, GO:0050767, GO:0014013, GO:0048869, GO:0050768, GO:0050789, GO:0008150, GO:0065007, GO:0044699, GO:0010721, GO:0048519, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0045596, GO:0045595, GO:0044763, GO:0051239, GO:0022008, GO:0051093, GO:0048699, GO:0044707, GO:0007399, GO:0048856, GO:0051960, GO:2000026, GO:0007275, GO:0048731, GO:0048523
GO:0043422 [MF]protein kinase B bindingprobableGO:0019899, GO:0019901, GO:0019900, GO:0003674, GO:0005488, GO:0005515
GO:0016042 [BP]lipid catabolic processprobableGO:0044238, GO:1901575, GO:0006629, GO:0044710, GO:0071704, GO:0008150, GO:0008152, GO:0009056
GO:0048471 [CC]perinuclear region of cytoplasmprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0060838 [BP]lymphatic endothelial cell fate commitmentprobableGO:0030154, GO:0072359, GO:0072358, GO:0045446, GO:0007275, GO:0044699, GO:0003158, GO:0001944, GO:0001945, GO:0008150, GO:0060836, GO:0030855, GO:0060839, GO:0032502, GO:0009987, GO:0032501, GO:0060429, GO:0009888, GO:0044767, GO:0044763, GO:0072148, GO:0045165, GO:0044707, GO:0048856, GO:0048869, GO:0048731
GO:0045177 [CC]apical part of cellprobableGO:0005575, GO:0044464, GO:0005623
GO:0001701 [BP]in utero embryonic developmentprobableGO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0043009, GO:0007275, GO:0044699
GO:0043401 [BP]steroid hormone mediated signaling pathwayprobableGO:0071383, GO:0023052, GO:0007165, GO:0070887, GO:0042221, GO:0050789, GO:0044699, GO:0009755, GO:0051716, GO:0033993, GO:0071310, GO:0065007, GO:0014070, GO:0071495, GO:0009719, GO:0009987, GO:0071396, GO:0050794, GO:0032870, GO:0044763, GO:0007154, GO:0010033, GO:0044700, GO:0071407, GO:0050896, GO:0009725, GO:0008150, GO:0048545
GO:0045736 [BP]negative regulation of cyclin-dependent protein serine/threonine kinase activityprobableGO:0033673, GO:0043549, GO:0019220, GO:0080090, GO:0019222, GO:0044092, GO:0031324, GO:0031323, GO:0009892, GO:0071901, GO:0071900, GO:0043086, GO:0051248, GO:0045786, GO:0051348, GO:0051246, GO:0050789, GO:0065007, GO:0031399, GO:0048519, GO:0065009, GO:0006469, GO:0045936, GO:0060255, GO:0045859, GO:0050794, GO:0051174, GO:0032268, GO:0008150, GO:0010605, GO:0042325, GO:0032269, GO:0042326, GO:0050790, GO:0051726, GO:0010563, GO:0031400, GO:0051338, GO:0001933, GO:0001932, GO:0000079, GO:0048523
GO:0045630 [BP]positive regulation of T-helper 2 cell differentiationprobableGO:0046638, GO:0046637, GO:0046635, GO:0046634, GO:0048583, GO:0050865, GO:0050863, GO:0045580, GO:0045582, GO:0050789, GO:0051249, GO:1902105, GO:0045628, GO:0002684, GO:0002682, GO:0048518, GO:0065007, GO:0045622, GO:0045624, GO:0002828, GO:0050793, GO:2000516, GO:2000514, GO:0050794, GO:0045597, GO:0045621, GO:0045595, GO:0008150, GO:0050870, GO:0051239, GO:0050867, GO:0050776, GO:0051094, GO:0051251, GO:1902107, GO:0002694, GO:0002697, GO:0002696, GO:2000026, GO:0045619, GO:0043370, GO:0043372, GO:0002699, GO:0048522
GO:0032753 [BP]positive regulation of interleukin-4 productionprobableGO:0051240, GO:0001817, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0032673, GO:0050789, GO:0001819
GO:0043277 [BP]apoptotic cell clearanceprobableGO:0006897, GO:0016192, GO:0006810, GO:0044765, GO:0008150, GO:0006909, GO:0051234, GO:0051179, GO:0044699
GO:0001662 [BP]behavioral fear responseprobableGO:0032501, GO:0044707, GO:0044708, GO:0050896, GO:0007610, GO:0006952, GO:0006950, GO:0002209, GO:0042596, GO:0033555, GO:0008150, GO:0044699
GO:0055088 [BP]lipid homeostasisprobableGO:0042592, GO:0008150, GO:0065008, GO:0065007, GO:0048878
GO:0005504 [MF]fatty acid bindingprobableGO:0043168, GO:0031406, GO:0008289, GO:0043167, GO:0003674, GO:0005488, GO:0033293
GO:0051099 [BP]positive regulation of bindingprobableGO:0008150, GO:0065009, GO:0051098, GO:0065007, GO:0044093
GO:0030308 [BP]negative regulation of cell growthprobableGO:0045926, GO:0040008, GO:0051128, GO:0008150, GO:0001558, GO:0065007, GO:0048519, GO:0050794, GO:0050789, GO:0048523
GO:0045947 [BP]negative regulation of translational initiationprobableGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:2000112, GO:0031324, GO:0031323, GO:0050789, GO:0051248, GO:0010605, GO:0019222, GO:0010608, GO:0051246, GO:2000113, GO:0065007, GO:0031326, GO:0048519, GO:0010468, GO:0060255, GO:0006446, GO:0009889, GO:0050794, GO:0008150, GO:0032269, GO:0032268, GO:0010556, GO:0017148, GO:0006417, GO:0010558, GO:0048523
GO:0021575 [BP]hindbrain morphogenesisprobableGO:0032502, GO:0044707, GO:0007420, GO:0007399, GO:0032501, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0030902, GO:0048731, GO:0009653, GO:0007275, GO:0044699, GO:0007417
GO:0030520 [BP]intracellular estrogen receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0030522, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0030518, GO:0007154, GO:0050789, GO:0044699
GO:0042974 [MF]retinoic acid receptor bindingprobableGO:0008134, GO:0035257, GO:0003674, GO:0005488, GO:0005515, GO:0051427, GO:0005102
GO:0008270 [MF]zinc ion bindingprobableGO:0043169, GO:0046914, GO:0043167, GO:0003674, GO:0005488, GO:0046872
GO:0032689 [BP]negative regulation of interferon-gamma productionprobableGO:0051241, GO:0032649, GO:0008150, GO:0001817, GO:0065007, GO:0051239, GO:0048519, GO:0050789, GO:0001818

Prediction of Enzyme Commission Number ?

No EC number assigned to the protein, probably not an enzyme!

Spatial Structural Prediction

Structural Models Based on Templates

Template: 2HAN, chain A
Confidence level:very confident
Coverage over the Query: 15-93
View the alignment between query and template
View the model in PyMOL